Risperdal Breast Cancer Lawsuit Guide: What You Need to Know

Developed Breast Cancer After Using Risperdal or Invega in New York? Legal Options May Be Available

If you’ve been diagnosed with breast cancer after taking Risperdal (risperidone), Zyprexa (olanzapine), or Invega (paliperidone), you’re not alone-and you’re not without recourse. These drugs are prescribed to manage serious psychiatric conditions like schizophrenia and bipolar disorder. But studies show that they may sharply increase the risk of breast cancer, particularly by disrupting hormone levels in the body.

Many patients-especially women and long-term users-have suffered in silence, unaware that their breast cancer could be linked to antipsychotic drugs and elevated prolactin levels. Our attorneys are investigating claims from people harmed by these medications and can help you understand if you qualify to file a Risperdal breast cancer lawsuit today.

Below, we outline the medical risks, the science, who may qualify for compensation, and what you can do right now to protect your rights.

How Risperdal, Zyprexa, and Invega Work-and Why They’re Dangerous

Risperdal (risperidone), Invega (paliperidone), and Zyprexa (olanzapine) are part of a drug class known as second-generation antipsychotics. They’re used to treat schizophrenia, bipolar disorder, and sometimes major depressive disorder. These medications help manage mood swings, hallucinations, and psychosis.

However, these drugs can cause hormonal imbalances by drastically raising prolactin-a hormone produced by the pituitary gland. Prolactin plays a natural role in milk production and breast tissue growth. But chronically high prolactin levels can stimulate abnormal breast tissue changes, increasing the risk of cancer in both women and men.

While Zyprexa has a milder effect, both Risperdal and Invega have been directly linked to hyperprolactinemia-induced breast cancer. In fact, some studies indicate that people taking prolactin-elevating antipsychotics are more than twice as likely to develop breast tumors.

Medical Researchers Categorize Antipsychotic Breast Cancer Risk by Hormonal Impact

A groundbreaking study from Washington University School of Medicine has provided important insights into how antipsychotic medications may increase the risk of breast cancer. The research team grouped antipsychotic drugs into three distinct categories based on their ability to raise prolactin levels-a hormone that plays a key role in breast tissue growth.

Category 1 drugs, such as risperidone (Risperdal), paliperidone (Invega), and haloperidol, were found to produce the highest prolactin levels. Category 2 drugs, including olanzapine (Zyprexa), iloperidone, and lurasidone, had a moderate impact on prolactin. Category 3 medications, like quetiapine, clozapine, and aripiprazole, caused little or no prolactin elevation.

When researchers compared women taking these drugs to those treated with lithium or anticonvulsants, they found the following:

• A 62% higher breast cancer risk for women on Category 1 drugs
• A 54% increase in risk for those on Category 2 drugs
• No elevated risk for users of Category 3 drugs

These findings strongly suggest that prolactin elevation is a major factor in cancer development among women taking certain antipsychotics. The classification system also gives attorneys powerful evidence when building product liability lawsuits against the makers of prolactin-elevating drugs like Risperdal and Invega.

Read the full research summary from Washington University School of Medicine.

Who’s Most at Risk for Breast Cancer from These Medications?

The longer a patient is on Risperdal, Zyprexa, or Invega, the greater the exposure to elevated prolactin. That means women who take these drugs for months or years-especially those in psychiatric facilities or long-term outpatient care-face the highest risk.

Breast cancer after Risperdal isn’t just a women’s issue. Men taking risperidone and paliperidone have reported breast tissue growth (gynecomastia), pain, nipple discharge, and even rare male breast cancers. Children and adolescents on these medications are also at heightened risk due to their hormonal sensitivity during puberty.

These risks are even more concerning when medical providers don’t monitor prolactin levels or provide appropriate follow-up screening. Our lawyers have seen cases where patients suffered for years before learning about the cancer risks tied to their psychiatric prescriptions.

What Breast Cancer Symptoms Should You Watch For?

If you’ve taken these medications, be alert for early signs of breast cancer:

• Unusual breast lumps or thickened areas
• Persistent breast pain or swelling
• Changes in nipple appearance or discharge
• Redness, scaling, or skin dimpling on the breast

Don’t wait for symptoms to worsen. Early detection is critical. If you’ve experienced these warning signs and have a history of using Risperdal, Zyprexa, or Invega, contact our team to review your potential claim confidentially.

The Science Linking Antipsychotics to Breast Cancer

Multiple peer-reviewed studies have uncovered troubling evidence. A Washington University School of Medicine analysis found that women prescribed risperidone or paliperidone had “significantly higher” rates of breast cancer compared to other patients. Another publication in Breast Cancer Research reported that high-prolactin antipsychotics may promote the growth of precancerous lesions into full tumors.

The FDA has received adverse event reports linking these drugs to breast cancer, and endocrinologists have long known about the role of prolactin in tumor formation. Yet, many physicians remain unaware of the full risks-often leaving patients in the dark.

This body of research has prompted growing litigation across the country against Johnson & Johnson (Risperdal, Invega) and Eli Lilly (Zyprexa).

History of Lawsuits and Manufacturer Accountability

Johnson & Johnson has already paid billions in settlements over Risperdal side effects, including gynecomastia cases. Zyprexa’s maker, Eli Lilly, settled thousands of claims tied to diabetes and metabolic disorders. Now, lawsuits are emerging that focus squarely on breast cancer caused by these medications.

These legal actions allege that the companies failed to warn doctors and patients, didn’t adequately study long-term risks, and continued to promote their drugs despite evidence of harm. If you’ve been diagnosed with breast cancer after using these medications, you may have the right to hold them accountable.

What Kind of Compensation Is Available?

If your breast cancer diagnosis can be linked to Risperdal, Invega, or Zyprexa, you may be eligible for damages, including:

• Medical expenses (diagnosis, surgery, chemotherapy, radiation)
• Lost income or job loss
• Emotional and physical suffering
• Long-term disability
• Punitive damages for corporate misconduct

Every case is unique. Our team at Alonso Krangle, LLP will work to determine how your treatment history, medical records, and expert testimony support your case. You deserve justice for what you’ve endured.

What to Do If You Suspect Your Breast Cancer Was Caused by These Drugs

The first step is preserving your medical records-especially your prescription history and any imaging, biopsy, or pathology reports. Create a timeline showing how long you were on the drug and when your symptoms began.

Then, contact our attorneys at Alonso Krangle, LLP. We offer free, confidential case reviews to help determine if your cancer diagnosis could be tied to your use of these antipsychotic drugs. There are strict time limits to file, so acting quickly can protect your rights.

We’re Here to Help You Pursue Justice

At Alonso Krangle, LLP, our legal team understands how devastating a breast cancer diagnosis can be-especially when it may have been preventable. If you used Risperdal, Zyprexa, or Invega and were later diagnosed with breast cancer, you may be eligible for compensation.

Call 800-403-6191 or submit the form on this page to schedule a free consultation. You’ll speak directly with one of our attorneys-no call centers, no pressure. Just real answers from real lawyers who are ready to fight for you.